Substance P in keratosis follicularis spinulosa decalvans  by Doche, Isabella et al.
CASE REPORTSubstance P in keratosis follicularis
spinulosa decalvans
Isabella Doche, MD,a Maria Hordinsky, MD,b George L. Wilcox, PhD,c Neusa S. Valente, MD, PhD,a and
Ricardo Romiti, MD, PhDa
S~ao Paulo, Brazil and Minneapolis, MinnesotaFrom
an
Ph
Fund
Confl
Corre
Vil
isaKey words: keratosis folicularis spinulosa decalvans; neurogenic inflammation; neuropeptide; substance P.Fig 1. KFSD. Scarring alopecia plaque on the vertex area of
the scalp with moderate perifollicular and diffuse scale.
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Keratosis follicularis spinulosa decalvans (KFSD)
is an inherited rare disorder characterized by diffuse
keratosis pilaris and scarring alopecia. Palmoplantar
keratoderma, ocular abnormalities, and atopy can
also be present.1,2 Most cases occur in males and
have a X-linked pattern of inheritance, although
autosomal dominant and sporadic cases have been
reported.2 The pathogenesis of this intriguing dis-
ease is not well understood. Substance P (SP), an
important marker of neurogenic inflammation, is
widely distributed in the central and peripheral
nervous systems. In the skin, SP-positive nerve
fibers can be normally present in the dermis and
epidermis.3 SP is considered a potent neuropeptide
vasodilator and has been associated with many
inflammatory processes, such as mast cell degranu-
lation and neutrophil/lymphocyte chemotaxis. SP
can also lower itch thresholds and stimulate fibrosis
and healing processes through fibroblast activa-
tion.4,5 Increased levels of SP have been reported
in many inflammatory skin conditions, including
alopecia areata, atopic dermatitis, and psoriasis.3,5,6
We describe a Brazilian girl with a generalized
severely pruritic scalp and typical features of KFSD
whose lesional skin scalp showed increased levels of
the neuropeptide SP. To our knowledge, this is the
first time this neuropeptide is reported in the setting
of KFSD.CASE REPORT
A 10-year-old white Brazilian girl with a 2-year
history of a severely pruritic scalp and progressive
hair loss was referred to the Hair Disease Clinic at the
University of Sao Paulo. At the time of presentation,the Department of Dermatology, University of S~ao Pauloa
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belladoche@gmail.com.she was taking 5 mg of folic acid since age 5 for a
congenital meningomielocele related to methylene-
tetrahydrofolate reductase gene deficiency. On
clinical examination, a scarring alopecia with peri-
follicular and diffuse scale on the vertex area was
noted (Fig 1). Keratosis pilaris was evident on the
face, limbs, and chest (Fig 2). Teeth, nails, palms, and
soles were normal. Ophthalmologic examinationJAAD Case Reports 2015;1:327-8.
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Fig 2. KFSD. Note characteristic keratosis pilaris on the
face.
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328 Doche et aland routine laboratory examination found no ab-
normalities. No family members were affected. Two
4-mm punch scalp biopsy sections were collected for
histopathologic analysis, one from the most affected
area (vertex) and one from a less affected area
(occipital). Histologic examination of vertical sec-
tions from the vertex area found perifollicular
lymphocytic chronic inflammatory infiltrate, hyper-
keratosis in the follicular ostium and fibrosis. Mild
perifollicular inflammation could also be noted in the
occipital biopsy. Direct immunofluorescence results
were negative for both sites. Because of the severe
pruritus in this patient, we decided to examine SP
expression using an enzyme-linked immunosorbent
assay technique on specimens obtained adjacent to
the previously biopsied sites. All scalp hairs were
plucked from tissue samples before homogenization
and centrifugion. The enzyme-linked immunosor-
bent assay analysis was performed using enzyme
immunoassay human SP kits from Cayman (Ann
Arbor, MI) and protocols validated by Societe dePharmacologie ET d’ImmunologieeBIO. The most
affected and symptomatic scalp area showed 37.2
pg/mL of SP compared with 31.3 pg/mL of SP in the
less affected area. Blood samples were also studied
and compared with scalp skin and blood samples of
11 control subjects. All serum and control samples
showed undetectable results.DISCUSSION
The role of neuropeptides in cutaneous innerva-
tion is well estabilished by in vitro, in vivo, and
clinical studies, and there is substantial evidence that
sensory neuropeptides contribute to the develop-
ment and maintenance of many inflammatory skin
conditions and symptoms such as pruritus.4 SP may
be related to the overt pruritus experienced by this
patient. Because treatment of KFSD is often unre-
warding, the finding of increased SP levels in this
patient suggests more studies of neurogenic inflam-
mation are needed to assess the pathogenesis of this
rare variant of cicatricial alopecia. New medications
that target neurogenic inflammation, such as a NK-1R
antagonist, may in the future benefit KFSD patients.
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